| 8:00 |
Registration |
|
| 8:30 |
Symposium Opening Event |
Prof. George Mellick |
| 9:30 |
Session 1: Therapeutic Horizons |
|
"Amyloid Beta and Drug Discovery in Alzheimers - are there lessons for Parkinson's?" |
Prof. Colin Masters, University of Melbourne |
|
"Current Clinic Trial Efforts in Parkinson's" |
Dr. Richard Wyse, Cure Parkinson's Trust UK |
|
"Advances in Neurosurgery for Neurodegenerative disease" |
Prof. Peter Silburn, University of Queensland |
| 10:30 |
Morning Tea |
|
| 11:00 |
Session 2: Biomarkers, Benchmarking and other Challenges |
|
|
"Genetic Analysis and the Clinician - using genetic analysis to guide therapy" |
Prof. Christine Klein, University of Luebeck Germany |
|
"The Australian Imaging Biomarkers and Lifestyle Project" |
Prof. Ashley Bush, Florey Institute |
| 13:00 |
Lunch (Exhibitors and Poster Session) |
|
| 14:00 |
Session 3: Cutting Edge Primary Research |
|
"Establishing a multi-disciplinary approach linking the clinic to research" |
Prof. Rejko Krueger, University of Luxembourg |
|
"Advances in complex genetic analysis - methylation and exposures" |
Dr. Jake Gratton, University of Queensland |
| 15:30 |
Afternoon Tea |
|
| 16:00 |
Session 3 Continues |
|
"Protein Trafficking in Neurodegenerative Diseases" |
Prof. Rohan Teasdale, University of Queensland |
|
"Blood biomarkers for Parkinson's" |
Prof. Antony Cooper, Garvan Institute |
| 18:00 |
"The James Parkinson" - Bicentenary Oration |
|
"Parkinson’s disease – personalized, precision medicine from 20 years of genetic insight" |
Prof. Matt Farrer, CSO of Neurocode, Department of Medical Genetics, University of British Columbia |
| 19:30 |
Symposium Dinner |
|
